Abstract
Riboflavin-ultraviolet A (UVA) collagen cross-linking (CXL) has been applied in clinical settings to prevent the progression of keratoconus and cornea......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
